GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the complex of pf-3450074 with an engineered HIV capsid N terminal domain

Analyse Crystal structure of the complex of pf-3450074 with an engineered HIV capsid N… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2XDE
Type
protein
Length
272 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Gag polyprotein
UniProt
Q9IQV5
Ligands
1B0
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 63% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGag polyproteinprotein13663% helix, 4% strandQ9IQV5

Ligands and binding sites

  • 1B0 · N-methyl-nalpha-[(2-methyl-1H-indol-3-yl)acetyl]-N-phenyl-L-phenylalaninamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13330.570.76381B0
2860.370.76131B0
3830.350.7619empty

Interfaces

1 interface between chains.

  • A–B · 451 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 2XDE · Crystal structure of the complex of PF-3450074 with an engineered HIV capsid N terminal… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.